Case–control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany
Authors:
- 5 March 2009
- journal article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 20 (6) , 965-980
Abstract
We report on a nested case–control study with 328 cases with second malignant neoplasm (SMN) following childhood cancer and 639 matched controls based on the German Childhood Cancer Registry. In the adjusted overall analysis, the odds ratio (OR) for SMN following any radiotherapy or chemotherapy is 2.1 [95% confidence interval (CI): 1.8–3.3] and 1.8 (95% CI: 0.98–3.1), respectively. The strongest effect is seen for alkylating agents (OR=2.0, 95% CI: 1.2–3.3). The risk of SMN after leukemia is pronounced for antimetabolites (OR=17.2, 95% CI: 1.7–177) and asparaginase (OR=4.3, 95% CI: 1.7–11.0). Following solid tumors, the greatest effect is seen for platinum derivatives (OR=4.1, 95% CI: 1.7–10.1). For anthracyclines, a decreased risk is observed (OR=0.3, 95% CI: 0.1–0.6). Secondary solid tumors are mainly associated with radiotherapy (OR=4.5, 95% CI: 2.5–8.0), especially secondary carcinomas. Secondary acute myeloid leukemia and myelodysplastic syndrome are mainly associated with alkylating agents (OR=8.5, 95% CI: 0.97–74.8), asparaginase (OR=6.8, 95% CI: 2.3–20.6), and platinum derivatives (OR=4.5, 95% CI: 1.5–13.6). The observed risks are in many instances lower than the ones published in previous studies relating to earlier treatment eras of the primary diseases. These differences may be attributed to less toxic but still effective treatment regimes but also to differences in the length of follow-up.Keywords
This publication has 36 references indexed in Scilit:
- Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic LeukemiaJAMA, 2007
- Risk of a second malignant neoplasm among 5‐year survivors of cancer in childhood and adolescence in British Columbia, CanadaPediatric Blood & Cancer, 2007
- Risk of second malignancies in long-term survivors of childhood cancerEuropean Journal of Cancer, 2007
- Trends in survival after childhood cancer in Europe, 1978–1997: Report from the Automated Childhood Cancer Information System project (ACCIS)European Journal of Cancer, 2006
- Late Effects after Therapy of Hodgkin's Disease: Update 2003/04 on Overwhelming Post-Splenectomy Infections and Secondary MalignanciesKlinische Padiatrie, 2004
- Long-term population-based risks of second malignant neoplasms after childhood cancer in BritainBritish Journal of Cancer, 2004
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Second tumoursEuropean Journal of Cancer, 2001
- Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 nordic countriesInternational Journal of Cancer, 2000
- Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentBritish Journal of Cancer, 1999